Alcohol Monitoring Systems, Inc. Acquires PharmChem, Inc.
July 21, 2025
PharmChem, Inc. entered into a definitive agreement to be acquired by Alcohol Monitoring Systems, Inc. Under the terms, PharmChem shareholders will receive $3.75 per share in cash. The transaction is subject to shareholder approval and customary closing conditions, and is expected to close before the end of the third quarter.
- Buyers
- Alcohol Monitoring Systems, Inc.
- Targets
- PharmChem, Inc.
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Pharmaron Acquires Absorption Systems
November 9, 2020
Healthcare Services
Pharmaron Beijing Co., Limited acquired 100% of Absorption Systems for up to US$137.5 million in cash. The purchase brings Absorption Systems’ non-clinical DMPK/ADME and bioanalysis capabilities and U.S. lab footprint (Philadelphia, San Diego and Boston) into Pharmaron’s integrated drug R&D services platform to expand capabilities and U.S. presence.
-
Meyer Lab Acquires AmChem Industrial
January 7, 2026
Manufacturing
Meyer Lab announced it has acquired AmChem Industrial, an Atlanta-area supplier of industrial and specialty cleaning chemicals. Meyer Lab said the acquisition supports its growth objectives by strengthening its presence in the Southeast and Texas and deepening customer relationships. Integration is already underway, with AmChem operations fully integrated into Meyer Lab.
-
ProPharma Group Acquires Pharmica Consulting
October 6, 2021
Healthcare Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.
-
Sygnature Discovery Acquires NuChem Sciences
August 1, 2023
Biotechnology
UK-based integrated drug discovery CRO Sygnature Discovery has acquired Montreal-headquartered NuChem Sciences, one of North America's largest discovery contract research organisations. The deal expands Sygnature's global footprint and capabilities in medicinal chemistry, DMPK, structural biology and in vitro/in vivo pharmacology, strengthening its position in the North American market.
-
Alchemer Acquires Chatmeter
September 24, 2025
Cloud & SaaS
Alchemer has acquired Chatmeter from PSG in a deal that expands Alchemer’s customer experience platform by combining direct feedback (surveys) with Chatmeter’s AI-powered reputation and indirect-feedback capabilities. Terms were not disclosed; the acquisition aims to create a unified feedback intelligence platform for multi-location brands across retail, hospitality, financial services and other industries.
-
Ellab Acquires PharmaSys, Inc.
May 3, 2023
Healthcare Services
Ellab has acquired PharmaSys, Inc., a Raleigh, North Carolina-based validation and CQV services firm with 17 employees, as part of Ellab's strategy to expand its US field services in the biopharma sector. The PharmaSys owners, Nancy K. Lankford and Charles L. Lankford, will remain through the transition before retiring this summer.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.